Units of Paradigm Real Estate Investment Trust (KL:PARADIGM) were flat in their debut on the Main Market and remained largely ...

Paradigm Real Estate Investment Trust (Paradigm-REIT) began trading on the Main Market of Bursa Malaysia today, opening at ...

Conference commissioners Jim Phillips, Greg Sankey, Tony Petitti, Brett Yormark and Teresa Gould spoke on next steps ...

The assessment of Crohn's disease activity through endoscopy is a cornerstone of both clinical management and research. In The Lancet Gastroenterology & Hepatology, Christopher Ma and colleagues ...

Vineeth Gogineni is a Manager at Bain & Company, based in the Dallas office, serving private and public sector clients across ...

The prior article in the two-part series challenged the traditional view of economics as merely the management of scarce ...

Long-term maintenance with P2Y12 inhibitor monotherapy after discontinuing dual antiplatelet therapy (DAPT) in patients ...

When a retailer offers a chatbot to communicate with customers and solve their queries, or when a bank sends an SMS for ...

Investing.com -- Shares of Axsome Therapeutics Inc (NASDAQ: AXSM) fell 1.2% following the U.S. Food and Drug Administration’s (FDA) Refusal to File (RTF) letter regarding the company’s New Drug ...

Paradigm’s new altimeter offers real-time operational data, including rate of descent, current atmospheric pressure, alerts ...

Axsome Therapeutics (AXSM) shares drop after FDA declines review of fibromyalgia treatment AXS-14. Read more here.

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...